Back to search results

Study of Breast Cancer Risk Factors and Outcomes in Florida

This observational study aims to understand why people in Florida have different risks for breast cancer and different outcomes after diagnosis. Researchers will collect blood and tissue samples during surgery, and you will complete surveys at the start of the study, after surgery, and at 1, 3, and 5 years later. This study is for men and women aged 18 and older who are seen at the University of Miami, Sylvester Comprehensive Cancer Center, or Jackson Health Systems for a breast biopsy, or are new breast patients at these locations. The study plans to enroll 800 participants. The main goal is to collect information about participants' health and experiences over time.

Study design
This is an observational study, meaning researchers will collect information without giving any specific treatments. It plans to include 800 participants.
What's involved
You would provide blood and tissue samples during surgery. You would also complete surveys at the start of the study, after surgery, and at 1, 3, and 5 years later.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for up to 5 years after joining the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06780176

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

Recruiting
Not specifiedAges 18+Observational
Memorial Sloan Kettering Cancer Center
~800 participants
Updated 2026-02-06 on ClinicalTrials.gov
What's tested:Biospecimen CollectionSurgical Tissue CollectionSurvey Collection

At a glance

Recruiting sites
2 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Clinical characteristic of participants (survey)
Measured over Up to 5 years

Conditions

Breast Cancer
Breast Neoplasms
Breast Diseases

Explore related trials

Breast Carcinoma

Where it's being run

3 sites across 3 states
California1
Florida1
New York1

Study leadership

  • Neha Goel, MD, MPH · PRINCIPAL_INVESTIGATOR · Memorial Sloan Kettering Cancer Center

Who to contact

Neha Goel, MD, MPH
[email protected]
646-888-4731
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients with BIRADS 0-5, seen in breast radiology clinic at University of Miami (UM), Sylvester Comprehensive Cancer Center (SCCC), Jackson Health Systems (JHS) for biopsy.
Any new breast patient seen at UM/SCCC or JHS will be invited to participate in the study.
Men and women 18 years of age and older are eligible to participate in the study.

Exclusion

Patients who are less than 18 years of age will be considered ineligible.
Patients unable to complete the survey.

What this trial measures

  • Clinical characteristic of participants (survey)Up to 5 years

    The purpose of this study is to prospectively collect and store clinical data, blood and tissue samples, and participant survey data to evaluate (epi) genomic and non-genomic causes of disparity.